What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 7 minute read Pharma Industry News Mural Oncology shareholders to receive fixed $2.035 per share as XOMA Royalty deal nears closing Mural Oncology confirms a fixed $2.035 per share cash payout as its acquisition by XOMA Royalty nears closing, locking in a definitive exit for investors. bySoujanya RaviNovember 26, 2025